How to Buy Aktis Oncology Stock
Aktis Oncology Inc
Aktis Oncology, Inc. operates as a clinical-stage oncology company that engages in the development of targeted radiopharmaceutical therapies for cancer treatment.
Aktis Oncology stock last closed at $16.88, down 4.47% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Biotechnology industry by N/A percentage points. Aktis Oncology stock is currently +14.67% from its 52-week low of $14.72, and -42.11% from its 52-week high of $29.16.
There are currently 53.4M AKTS shares outstanding. The market capitalization of AKTS is $901.45M. In the last 24 hours, 261,000 AKTS shares were traded.
How to Buy Aktis Oncology Stock
Not sure how to invest in Aktis Oncology stock? Here's how.
- Figure out where to buy Aktis Oncology stock: You need to choose a stock brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you decide where to buy Aktis Oncology stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit money your investment account: Choose your method of payment and add your information.
- Research Aktis Oncology stock: The Aktis Oncology ticker symbol is AKTS. Is Aktis Oncology stock a good investment? Should you buy shares of AKTS? How do AKTS's underlying business fundamentals look? Do top analysts think Aktis Oncology is a good buy? Why has AKTS's stock price moved recently? (Hint: Our stock research website can help you evaluate if AKTS is a good stock to buy).
- Execute your AKTS trade: Decide if you will purchase AKTS shares at the current market price or use a limit order to buy AKTS shares at a specific price.
- Get key alerts regarding your AKTS investment: Create a watchlist to watch your position in Aktis Oncology shares.
Step 1: Figure out where to buy Aktis Oncology stock
You will need an online brokerage account in order to access the NASDAQ market and buy AKTS stock.
Our favorite brokerage: eToro
In our opinion, eToro is the best place to buy stocks. Here's why:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global markets: From Tech to Energy, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've chosen the right brokerage, you need to fill out some personal info so you are able to invest in AKTS stock today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to start a new trading account.
- Submit your details by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you've finished signing up on the best stock trading app, your next step is to transfer the money for your investment:
Check out the tutorial below for more details depositing money into your new investment account.
Step 4: Research Aktis Oncology stock
After you have decided on the best place to buy Aktis Oncology stock, it's critical to analyze their stock before you buy, so you truly wrap your head around the risk and opportunity.
Aktis Oncology stock at a glance
Aktis Oncology Fundamentals
WallStreetZen was built to help everyday investors perform more accurate fundamental analysis.
You can view all of the due diligence checks on AKTS's stock page.
Is AKTS stock properly valued?
Analysts use many financial metrics, analyses, models, and charts to gauge AKTS's true value.
You can do additional valuation research on AKTS's stock here.
AKTS Financial Health
Pros:
- There are more short-term assets than short-term liabilities on the AKTS balance sheet.
- AKTS has cash burn of 73711000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the AKTS balance sheet.
- AKTS has $227.94M in cash and short term investments. This is enough to cover its annual cash burn of $73.71M.
Cons:
- AKTS debt to equity ratio of -0.53 is negative.
- AKTS profit margin has gone up by 19.77 percentage points in the past year, but the company is still unprofitable.
- Total AKTS debt is still negative.
Is AKTS stock a Buy, Hold, or Sell, according to analysts?
Out of 2 Equities analysts who monitor AKTS, the consensus analyst rating on Aktis Oncology is a Strong Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are projecting on the Aktis Oncology stock forecast page.
AKTS Technical Indicators
AKTS Growth Numbers
Last year, AKTS revenue was $6.50M. Over the last 1 years, AKTS's revenue has grown by 336.92% per year. This was faster than the Biotechnology industry average of 28.3%.
Dive into AKTS's earnings and revenue performance here.
Are AKTS insiders buying or selling the stock?
In the past year, executives and large shareholders at AKTS have bought more shares than they have sold.
Ecor1 Capital LLC, Director of AKTS, was the latest AKTS insider to buy. They bought $37,400,022.00 worth of AKTS stock on Jan 12, 2026.
Get more info about who owns AKTS stock here.
Can I get consistent income from AKTS stock?
No, Aktis Oncology doesn't provide an income stream by paying out dividends.
What others are saying about AKTS
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Execute your AKTS trade
You have two main order types:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are generally the best for newer investors. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a given price limit, place a limit order.
Press the Open Trade button and your broker will place your order.
If you want additional help buying stocks on eToro, watch the helpful video below:
Step 6: Get key alerts regarding your AKTS investment
Now that you own some AKTS stock, you'll want to keep up with your new company.
Create a watchlist to get notified of important updates regarding your AKTS stock.
AKTS Feed
How to Buy Stock in Aktis Oncology
To reiterate, here are the 6 steps to buy stock in Aktis Oncology:
- Figure out where to buy Aktis Oncology stock
- Sign up for your brokerage account
- Deposit money your investment account
- Research Aktis Oncology stock
- Execute your AKTS trade
- Get key alerts regarding your AKTS investment
If you need a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to track your investment in Aktis Oncology, create a watchlist on WallStreetZen today.
Other "How To" Guides You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.